India markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
126.70-0.60 (-0.47%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5170.8B
Enterprise value 3186.65B
Trailing P/E 56.09
Forward P/E 122.15
PEG Ratio (5 yr expected) 13.19
Price/sales (ttm)6.12
Price/book (mrq)3.36
Enterprise value/revenue 36.68
Enterprise value/EBITDA 729.57

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 328.32%
S&P500 52-week change 344.45%
52-week high 3132.30
52-week low 387.68
50-day moving average 3124.21
200-day moving average 3116.69

Share statistics

Avg vol (3-month) 34.74M
Avg vol (10-day) 34.58M
Shares outstanding 51.35B
Implied shares outstanding 6N/A
Float 1.35B
% held by insiders 10.07%
% held by institutions 183.38%
Shares short (14-Apr-2021) 411.66M
Short ratio (14-Apr-2021) 42.32
Short % of float (14-Apr-2021) 40.87%
Short % of shares outstanding (14-Apr-2021) 40.87%
Shares short (prior month 14-Mar-2021) 47.51M

Dividends & splits

Forward annual dividend rate 42.32
Forward annual dividend yield 41.83%
Trailing annual dividend rate 32.28
Trailing annual dividend yield 31.79%
5-year average dividend yield 42.08
Payout ratio 4107.04%
Dividend date 315-Apr-2021
Ex-dividend date 424-Mar-2021
Last split factor 22:1
Last split date 326-Sep-1999

Financial highlights

Fiscal year

Fiscal year ends 23-Apr-2020
Most-recent quarter (mrq)28-Jan-2021

Profitability

Profit margin 10.97%
Operating margin (ttm)13.67%

Management effectiveness

Return on assets (ttm)2.51%
Return on equity (ttm)5.97%

Income statement

Revenue (ttm)27.93B
Revenue per share (ttm)20.79
Quarterly revenue growth (yoy)0.80%
Gross profit (ttm)19.64B
EBITDA 6.31B
Net income avi to common (ttm)3.06B
Diluted EPS (ttm)2.26
Quarterly earnings growth (yoy)-33.70%

Balance sheet

Total cash (mrq)14.64B
Total cash per share (mrq)10.86
Total debt (mrq)30.32B
Total debt/equity (mrq)59.54
Current ratio (mrq)2.10
Book value per share (mrq)37.67

Cash flow statement

Operating cash flow (ttm)5.94B
Levered free cash flow (ttm)5.46B